サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1347189

米国と欧州の遺伝子編集市場の2030年までの予測- 技術、製品・サービス、用途、エンドユーザー別の国別分析

US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology, Product and Service, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 146 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
米国と欧州の遺伝子編集市場の2030年までの予測- 技術、製品・サービス、用途、エンドユーザー別の国別分析
出版日: 2023年08月10日
発行: The Insight Partners
ページ情報: 英文 146 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国およびEUの遺伝子編集市場は、2022年の39億5,509万米ドルから2030年には150億5,292万米ドルに達すると予測されており、2022年から2030年までのCAGRは18.2%で成長すると予測されています。

がんやその他の遺伝性疾患の有病率の上昇、遺伝子編集ツールの継続的な技術進歩などの要因が、米国およびEUの遺伝子編集市場の成長を促進すると予想されます。さらに、バイオテクノロジーにおける技術革新と投資の増加も、予測期間中の米国およびEUの遺伝子編集市場の成長を促進すると予想されます。しかし、遺伝子編集法の生産コストが高いことが、米国およびEUの遺伝子編集市場の成長を阻害する可能性があります。

新製品開拓に向けた市場プレイヤーの戦略的取り組みが今後の米国・EU遺伝子編集市場を押し上げる

ヘルスケアITの技術開発により、CRISPRシステムの製造に人工知能（AI）を使用できるようになっています。ヘルスケアIT領域で働く開発者たちは、製品開発の全段階を制御・監視するためのプロセス分析に従事しています。バイオマーカーの発見から臨床試験、患者のモニタリングに至るまでの技術開発に重点を置いています。AIをデジタル製造に活用するための専門技術の導入に着手した企業もいくつかあります。2023年2月、CRISPR、合成生物学、人工知能（AI）技術を開発するシャーロック・バイオサイエンシズは、英国オックスフォードを拠点に迅速分子検査プラットフォームを開発するセンス・バイオデテクション社を買収しました。この買収により、シャーロックは最先端のCRISPRベースの診断法を世界の消費者の手に便利に届ける能力を加速させる。

2020年1月、ERS Genomics社とNew England Biolab社は、CRISPR遺伝子改変ツールおよび試薬の開発と商品化のために提携しました。New England Biolab社は、ゲノム研究のための組換え酵素とネイティブ酵素の最大の品揃えを提供しています。同社は、ゲノム編集を含む新しい研究分野への製品提供を拡大し続けています。CRISPR/Cas9試薬とツールのプロバイダーとして、NEBはERS Genomicsからのライセンスにより、これらの技術を使用・販売する権利を拡大しました。

したがって、このような取り組みがゲノム編集を促進し、今後数年間で米国およびEUの遺伝子編集市場の成長を高めると予想されます。

米国およびEUの遺伝子編集市場は、技術、製品・サービス、用途、エンドユーザーに基づいて区分されます。技術ベースでは、CRISPR、TALEN、アンチセンス、ジンクフィンガーヌクレアーゼ（ZFNs）、その他に区分されます。2022年には、CRISPRセグメントが米国およびEUの遺伝子編集市場で最大のシェアを占めました。さらに、同じセグメントはまた、今後数年の間に最も速い速度で成長すると予想されています。製品とサービスに基づくと、試薬と消耗品、機器、その他に区分されます。2022年には、試薬および消耗品セグメントが米国およびEUの遺伝子編集市場で最大のシェアを占めました。さらに、同セグメントは今後数年間、最も速い速度で成長することも予想されています。用途別では、細胞株工学、遺伝子工学、診断用途、創薬、その他に区分されます。2022年には、細胞株工学分野が市場で最大のシェアを占めました。さらに、同セグメントは今後数年間、最も速い速度で成長する見込みです。エンドユーザーに基づくと、製薬・バイオテクノロジー企業、学術・研究機関、契約研究機関（CRO）、その他に区分されます。2022年には、製薬＆バイオテクノロジー企業セグメントが米国＆EU遺伝子編集市場で最大のシェアを占めました。しかし、学術・研究機関セグメントは、今後数年間で最も速い速度で成長すると予想されています。

世界保健機関（WHO）、農業ゲノム研究センター（CRAG）、疾病対策予防センター（CDC）、環境・食糧・農村地域省（DEFRA）、食糧農業機関（FAO）、米国食品医薬品局（FDA）、イタリア農業遺伝学会（SIGA）などは、米国およびEUの遺伝子編集市場に関する報告書を作成する際に参照した一次調査と二次調査の情報の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 米国と欧州の遺伝子編集市場- 市場情勢

  • 概観
  • PEST分析
    • 米国-PEST分析
    • 欧州-PEST分析
  • 専門家の見解

第5章 遺伝子編集市場- 主な市場力学

  • 市場促進要因
    • がんおよびその他の遺伝子疾患の有病率の上昇
    • 遺伝子編集ツールの継続的な技術進歩
  • 市場抑制要因
    • 遺伝子編集手法の生産コストの高さ
  • 市場機会
    • 米国および欧州におけるバイオテクノロジー産業の成長
  • 今後の動向
    • 新製品開発に向けた市場プレイヤーの戦略的取り組み
  • インパクト分析

第6章 遺伝子編集市場：米国と欧州の分析

  • 米国と欧州の遺伝子編集市場の収益予測と分析
  • 主要プレイヤーの市場ポジショニング

第7章 遺伝子編集市場米国と欧州の遺伝子編集市場分析-技術別

  • CRISPR
  • TALEN
  • アンチセンス
  • ジンクフィンガーヌクレアーゼ（ZFNs）
  • その他

第8章 米国と欧州の遺伝子編集市場分析-製品・サービス別

  • 試薬・消耗品
  • 器具
  • その他

第9章 米国と欧州の遺伝子編集市場分析-用途別

  • 細胞株工学
  • 遺伝子工学
  • 診断アプリケーション
  • 創薬
  • その他

第10章 欧米遺伝子編集市場分析：エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • 開発業務受託機関（CRO）
  • その他

第11章 米国と欧州の遺伝子編集市場分析

  • 米国遺伝子編集市場の収益と予測・分析
  • 欧州遺伝子編集市場の収益と予測分析

第12章 業界情勢

  • 米国と欧州の遺伝子編集市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Lonza Group AG
  • Horizon Discovery Group plc.
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • New England Biolabs
  • Eurofins Scientific SE
  • CRISPR Therapeutics
  • Editas Medicine Inc
  • ElevateBio LLC

第14章 付録

図表

List Of Tables

  • Table 1. US: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 2. US: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 3. US: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 4. US: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 5. Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 7. Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 8. Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 9. Germany: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Germany: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Germany: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 12. Germany: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 13. UK: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 14. UK: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 15. UK: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 16. UK: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 17. France: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 18. France: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 19. France: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 20. France: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 21. Italy: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 22. Italy: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Italy: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 24. Italy: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 25. Spain: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Spain: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 27. Spain: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 28. Spain: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 32. Rest of Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
  • Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
  • Table 35. Glossary of Terms, Gene Editing Market

List Of Figures

  • Figure 1. Gene Editing Market Segmentation
  • Figure 2. Gene Editing Market Segmentation, by Region
  • Figure 3. US and Europe Gene Editing Market Overview
  • Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
  • Figure 5. UK to Show Significant Growth During Forecast Period
  • Figure 6. US and Europe Gene Editing Market - Leading Country Markets (US$ Million)
  • Figure 7. US and Europe Gene Editing Market, Industry Landscape
  • Figure 8. US PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Gene Editing Market - Key Industry Dynamics
  • Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
  • Figure 12. US and Europe Gene Editing Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
  • Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
  • Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
  • Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
  • Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
  • Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 35. US Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
  • Figure 36. Europe Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
  • Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
  • Figure 38. Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 39. UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 40. France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 41. Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 42. Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 43. Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 44. Growth Strategies in US and Europe Gene Editing Market
目次
Product Code: TIPRE00029986

The US & EU gene editing market is projected to reach US$ 15,052.92 million by 2030 from US$ 3,955.09 million in 2022; it is expected to grow at a CAGR of 18.2% from 2022 to 2030.

The factors such as rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools are expected to drive the US & EU gene editing market growth. Moreover, growing innovations and rising investments in biotechnology is also expected to foster the US & EU gene editing market growth during the forecast period. However, the high cost of production of gene editing methods may hinder the US & EU gene editing market growth.

Strategic Initiatives by Market Players to Develop New Products to Boost the US & EU Gene Editing Market in Future

Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In February 2023, Sherlock Biosciences, which develops CRISPR, synthetic biology, and artificial intelligence (AI) technologies, acquired Sense Biodetection, an Oxford, UK-based developer of a rapid molecular testing platform. This acquisition accelerates Sherlock's ability to put the most advanced CRISPR-based diagnostics conveniently in the hands of global consumers.

In January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools and reagents. New England Biolab offers the largest selection of recombinant and native enzymes for genomic research. The company continues expanding its product offerings into new research areas, including genome editing. As a provider of CRISPR/Cas9 reagents and tools, NEB's license from ERS Genomics expands the company's rights to use and sell these technologies.

Thus, such initiatives are expected to foster genome editing and enhance the US & EU gene editing market growth in the coming years.

The US & EU gene editing market is segmented on the basis of technology, product and services, application, and end user. Based on the technology is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the products and services is segmented into reagents and consumables, instruments, and others. In 2022, the reagents and consumables segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the application is segmented into cell line engineering, genetic engineering, diagnostic application, drug discovery, and others. In 2022, the cell line engineering segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the end user is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organization (CROs), others. In 2022, the pharmaceutical & biotechnology companies segment held the largest share of the US & EU gene editing market. However, the academic and research institutes segment is expected to grow at the fastest rate during the coming years.

The World Health Organization (WHO), Centre For Research in Agricultural Genomics (CRAG), Centers for Disease Control and Prevention (CDC), Department For Environment, Food, And Rural Affairs (DEFRA), Food And Agricultural Organization (FAO), US Food and Drug Administration (FDA), Italian Society of Agricultural Genetics (SIGA) are among some of the primary and secondary sources referred to while preparing the report on the US & EU gene editing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the US and Europe Gene editing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the US and Europe Gene editing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 US and Europe Gene Editing Market- By Technology
    • 1.3.2 US and Europe Gene Editing Market- By Products and Services
    • 1.3.3 US and Europe Gene Editing Market- By Application
    • 1.3.4 US and Europe Gene Editing Market- By End User
    • 1.3.5 Gene Editing Market- By Geography

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. US and Europe Gene Editing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 US - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
  • 4.3 Expert Opinions

5. Gene Editing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
    • 5.1.2 Continuous Technological Advancements in Gene Editing Tools
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Production of Gene Editing Methods
  • 5.3 Market Opportunities
    • 5.3.1 Growing Biotechnology Industry in US and Europe
  • 5.4 Future Trends
    • 5.4.1 Strategic Initiatives by Market Players to Develop New Products
  • 5.5 Impact Analysis

6. Gene Editing Market - US and Europe Analysis

  • 6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
  • 6.2 Market Positioning of Key Players

7. US and Europe Gene Editing Market Analysis - By Technology

  • 7.1 Overview
    • 7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
  • 7.2 CRISPR
    • 7.2.1 Overview
    • 7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.3 TALEN
    • 7.3.1 Overview
    • 7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.4 Antisense
    • 7.4.1 Overview
    • 7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.5 Zinc Finger Nucleases (ZFNs)
    • 7.5.1 Overview
    • 7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

8. US and Europe Gene Editing Market Analysis - By Products and Services

  • 8.1 Overview
    • 8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
  • 8.2 Reagents and Consumables
    • 8.2.1 Overview
    • 8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • 8.3 Instruments
    • 8.3.1 Overview
    • 8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

9. US and Europe Gene Editing Market Analysis - By Application

  • 9.1 Overview
    • 9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
  • 9.2 Cell Line Engineering
    • 9.2.1 Overview
    • 9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.3 Genetic Engineering
    • 9.3.1 Overview
    • 9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.4 Diagnostic Application
    • 9.4.1 Overview
    • 9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.5 Drug Discovery
    • 9.5.1 Overview
    • 9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

10. US and Europe Gene Editing Market Analysis - By End User

  • 10.1 Overview
    • 10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
  • 10.2 Pharmaceutical & Biotechnology Companies
    • 10.2.1 Overview
    • 10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.3 Academic and Research Institutes
    • 10.3.1 Overview
    • 10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.4 Contract Research Organization (CROs)
    • 10.4.1 Overview
    • 10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

11. US and Europe Gene Editing Market Analysis

  • 11.1 US Gene Editing Market Revenue Forecast and Analysis
    • 11.1.1 Overview
    • 11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
    • 11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
    • 11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
    • 11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
    • 11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
  • 11.2 Europe Gene Editing Market Revenue Forecast and Analysis
    • 11.2.1 Overview
    • 11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
    • 11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
    • 11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
    • 11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
    • 11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
    • 11.2.8 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.8.1 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.9 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.9.1 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.10 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.10.1 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.11 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.11.1 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.12 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.12.1 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.13 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.13.1 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in US and Europe Gene Editing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Merck KGaA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lonza Group AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Horizon Discovery Group plc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Integrated DNA Technologies, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 GenScript Biotech Corporation
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 New England Biolabs
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eurofins Scientific SE
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 CRISPR Therapeutics
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Editas Medicine Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 ElevateBio LLC
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms